India's Sun Pharma to buy Organon in $11.75 billion all-cash deal

April 26 (Reuters) - India's Sun Pharmaceutical Industries will buy Organon & Co in an all‑cash deal, valuing the U.S.

Sun Pharma to buy Organon in $11.75B deal, expanding global reach

Sun Pharmaceutical Industries on Sunday said it agreed to acquire Organon & Co. (OGN) in an all-cash transaction valuing the company at an enterprise value of $11.75 billion, marking one of the ...

Sun Pharma to Acquire US-Listed Organon in $12 Billion Deal

Sun Pharmaceutical Industries Ltd. agreed to acquire New York-listed women’s health-care company Organon & Co., in what is ...
CNBCTV18

Sun Pharma to acquire Organon in an all-cash transaction worth $11.75 billion Enterprise Value

Sun Pharma will acquire 100% of Organon's outstanding equity at an enterprise value of $11.75 billion, it said in an exchange ...

Sun Pharma signs Definitive Agreement to Acquire Organon

Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its ...
BioSpace

Unnamed pharma files citizen petition targeting FDA’s trove of rejection letters

The FDA in July 2025 made publicly available over 200 complete response letters—an initiative that the investment community ...
Fierce Biotech

From debt to ‘acceptable’ prices: Roche CEO lists 3 reasons for sitting out Big Pharma M&A spree

While Big Pharmas embarked on a frenzy of acquisitions over recent weeks, Roche’s CEO has explained to Fierce Biotech why the ...

Judge postpones OxyContin-maker Purdue Pharma’s sentencing to let opioid victims attend in person

A judge has rescheduled a hearing in which she is expected to sentence OxyContin maker Purdue Pharma to forfeit $225 million ...

Join Lantern Pharma on April 30 for the First Public Demonstration of withZeta.ai – A Platform to Conquer Rare Cancers

CEO Panna Sharma to Lead Live, Unscripted Platform Walkthrough in Two Interactive Sessions on April 30, 2026 - Open to ...

Big Pharma Is Thinking Small on Deals. That’s a Boon for Biotech.

Smaller acquisitions and disciplined pricing are proving to be big benefits to a wider number of companies ...
Medical Marketing & Media

What to make of the FDA’s increased focus on pharma’s social media ads

If the crackdown on pharma’s TV ads and subsequent extension to social media has underscored anything, it’s that brands need ...

CORRECTION: Join Lantern Pharma on April 30 for the First Public Demonstration of withZeta.ai – A Platform to Conquer Rare Cancers

This version updates the headline which had a misspellingCEO Panna Sharma to Lead Live, Unscripted Platform Walkthrough ...